Solvay reports Q3 2026 sales down 3.3% amid Middle East conflict, advances rare earths strategy with Viridis deal.
Solvay's Q3 2026 underlying net sales fell 3.3% organically to €1,031 million, impacted by the Middle East conflict and weak soda ash markets. EBITDA dropped 26.6% organically to €173 million, partly due to a €25 million impact from the conflict and ...


